ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.56
0.59%
After-hours: Aug 15, 2025, 07:58 PM EDT
ImmunityBio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 137.66M | 60.66M | 143.43M | 111.97M | 130.1M | 133.03M | 265.45M | 177.96M | 43.51M | 88.48M | 104.64M | 104.16M | 61.9M | 36.38M | 181.1M | 64.52M | 83.96M | 44.68M |
Short-Term Investments | 16M | 931K | 6.38M | 18.4M | 87.88M | 37.46M | 1.01M | 11.83M | 2.45M | 2.79M | 2.54M | 6.9M | 21.04M | 155.95M | 136.01M | 15.85M | 19.97M | 38.59M |
Long-Term Investments | n/a | n/a | n/a | 7.07M | 7M | 6.94M | 8.1M | 817K | 841K | 820K | 5.7M | 811K | 914K | 865K | 6.78M | 13.72M | 13.04M | 8.2M |
Other Long-Term Assets | 11.24M | 12.1M | 11.96M | 3.64M | 2.64M | 2.69M | 2.49M | 3.43M | 3.77M | 12.06M | 6.63M | 12.51M | 6.02M | 12.76M | 7.2M | 538K | 553K | 495K |
Receivables | 22.33M | 17.45M | 2.65M | 4.17M | 2.06M | 2.14M | 3.17M | 2.33M | 3.28M | 1.46M | 1.89M | 6.49M | 1.45M | 3.89M | 1.33M | 1.3M | 2.05M | 5.43M |
Inventory | 6.64M | 8.44M | 8.27M | 1.96M | 1.81M | n/a | n/a | 16.24M | 13.04M | 15.97M | 26.35M | 19.85M | 2.16M | 12.13M | n/a | 7.89M | 6.85M | 9.96M |
Other Current Assets | 1.64M | 2.35M | 2.55M | 11.44M | 955K | 3.91M | 5.21M | 6.72M | 4.55M | 4.79M | 5.15M | 5.7M | 8M | 3.98M | 5.55M | 4.39M | 910K | 909K |
Total Current Assets | 208.13M | 109.16M | 184.59M | 163.15M | 242.83M | 195.72M | 294.08M | 215.08M | 66.83M | 113.49M | 140.58M | 143.09M | 114.99M | 212.34M | 334.35M | 94.45M | 113.73M | 99.57M |
Property-Plant & Equipment | 167.73M | 167.05M | 170.46M | 174.23M | 175.79M | 178.75M | 182.68M | 187.81M | 194.04M | 198.36M | 189.45M | 176.87M | 167.55M | 141.11M | 119.17M | 103.98M | 117.25M | 99.32M |
Goodwill & Intangibles | 14.98M | 15.44M | 15.93M | 16.48M | 16.06M | 16.57M | 17.09M | 18.47M | 18.99M | 19.5M | 20M | 20.47M | 21.74M | 22.35M | 1.42M | 1.56M | 1.55M | 1.67M |
Total Long-Term Assets | 193.94M | 194.6M | 198.35M | 201.42M | 201.5M | 204.96M | 210.37M | 217.34M | 224.4M | 229.91M | 221.78M | 209.85M | 202.73M | 177.25M | 134.56M | 119.97M | 132.57M | 109.86M |
Total Assets | 402.08M | 303.76M | 382.93M | 364.57M | 444.32M | 400.68M | 504.45M | 432.42M | 291.23M | 343.4M | 362.36M | 352.94M | 317.72M | 389.59M | 468.91M | 214.42M | 246.3M | 209.43M |
Account Payables | 7.42M | 13.5M | 6.72M | 9.95M | 20.32M | 13.87M | 9.2M | 19.82M | 25.49M | 33.57M | 21.02M | 20.24M | 18.05M | 9.83M | 11.42M | 15.12M | 19.15M | 20.1M |
Deferred Revenue | n/a | n/a | n/a | n/a | 100K | 100K | 100K | 100K | -518.51M | 100K | 100K | 100K | -1.4M | 100K | n/a | 145K | 217K | 263K |
Short-Term Debt | n/a | 7.46M | 1.25M | 2.16M | n/a | n/a | n/a | n/a | 518.51M | 471.48M | 431.9M | n/a | 300.08M | 299.61M | 299.24M | n/a | 627K | 571K |
Other Current Liabilities | 17.02M | 4.72M | 14.73M | 41.43M | 13.54M | 9.29M | 18.31M | 15.97M | 25.09M | 20.96M | 19.74M | 15.7M | 13.03M | 10.23M | 49.72M | 10.14M | 47.91M | 50M |
Total Current Liabilities | 50.64M | 49.2M | 54.94M | 60.96M | 62.11M | 53.76M | 58.28M | 90.32M | 613.48M | 564.95M | 500.86M | 70.84M | 376.05M | 381.01M | 369M | 65.41M | 74.43M | 79.86M |
Long-Term Debt | 492.08M | 485.72M | 461.88M | 699.12M | 956.26M | 850.5M | 681.54M | 673.59M | 250.1M | 245.64M | 241.27M | 710.62M | 363.19M | 345.68M | 306.35M | 337.88M | 329.37M | 313.84M |
Other Long-Term Liabilities | 393.33M | 29.93M | 35.01M | 38.24M | 86.91M | 149.2M | 310.63M | 39.84M | 28.27M | 18.24M | 22.03M | -48.99M | -50.36M | -35.96M | 249K | -33.74M | -28.2M | -15.66M |
Total Long-Term Liabilities | 921.25M | 845.04M | 816.12M | 1.05B | 1.08B | 1.04B | 1.03B | 752.74M | 322.93M | 310.17M | 311.31M | 711.18M | 363.64M | 346.13M | 343.83M | 338.96M | 330.46M | 314.9M |
Total Liabilities | 971.89M | 894.24M | 871.06M | 1.11B | 1.14B | 1.09B | 1.09B | 843.06M | 936.41M | 875.12M | 812.18M | 782.02M | 739.69M | 727.14M | 712.82M | 404.37M | 404.89M | 394.76M |
Total Debt | 535.32M | 526.27M | 504.17M | 742.91M | 998.96M | 895.42M | 883.68M | 717.27M | 819.16M | 766.25M | 723.77M | 711.98M | 664.68M | 648.8M | 645.66M | 340.95M | 331.8M | 319M |
Common Stock | 91K | 85K | 85K | 70K | 69K | 68K | 67K | 67K | 44K | 43K | 42K | 40K | 40K | 40K | 40K | 39K | 39K | 38K |
Retained Earnings | -3.6B | -3.5B | -3.38B | -3.32B | -3.23B | -3.1B | -2.96B | -2.73B | -2.63B | -2.49B | -2.38B | -2.27B | -2.16B | -2.06B | -1.96B | -1.87B | -1.78B | -1.69B |
Comprehensive Income | 12.57M | 19.96M | 1.2M | 103K | -8K | -7K | 10K | 792K | -40K | -33K | 183K | -190K | -110K | -367K | 4K | 53K | 37K | -38K |
Shareholders Equity | -570.75M | -591.43M | -489.1M | -744.16M | -698.39M | -692.01M | -586.99M | -411.72M | -642.12M | -528.98M | -447.33M | -426.7M | -419.81M | -335.64M | -242.17M | -188.5M | -157.94M | -185.79M |
Total Investments | 16M | 931K | 6.38M | 18.4M | 94.88M | 44.4M | 9.11M | 11.83M | 2.45M | 2.79M | 8.24M | 6.9M | 21.95M | 156.81M | 142.79M | 15.85M | 19.97M | 38.59M |